• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Med (Lausanne) . COVID-19 and Acute Kidney Injury: A Systematic Review

tetano

Editor, Senior Moderator
Front Med (Lausanne)


. 2022 Apr 4;9:705908.
doi: 10.3389/fmed.2022.705908. eCollection 2022.
COVID-19 and Acute Kidney Injury: A Systematic Review


Tahereh Sabaghian[SUP] 1 [/SUP], Amir Behnam Kharazmi[SUP] 2 [/SUP], Ali Ansari[SUP] 3 [/SUP], Fatemeh Omidi[SUP] 4 [/SUP], Seyyedeh Neda Kazemi[SUP] 5 [/SUP], Bahareh Hajikhani[SUP] 6 [/SUP], Roya Vaziri-Harami[SUP] 7 [/SUP], Ardeshir Tajbakhsh[SUP] 8 [/SUP], Sajjad Omidi[SUP] 3 [/SUP], Sara Haddadi[SUP] 9 [/SUP], Amir Hashem Shahidi Bonjar[SUP] 10 [/SUP], Mohammad Javad Nasiri[SUP] 6 [/SUP], Mehdi Mirsaeidi[SUP] 11 [/SUP]



Affiliations

Abstract

Introduction: Acute kidney injury (AKI) has been associated with an increased mortality rate among hospitalized patients with Coronavirus disease 2019 (COVID-19). The current review aimed to evaluate the symptoms, complications, and treatments performed to manage AKI in patients with COVID-19.
Methods: We searched PubMed/Medline, Web of Science, and Embase for the relevant scientific literature published up to February 1, 2022. The following keywords were used: "COVID-19", "SARS-CoV-2", and "Acute kidney injury".
Results: Forty-four studies with a total number of 114 COVID-19 patients with AKI (Mean age: 53.6 years) were included in our systematic review. The most common comorbidities in patients with COVID-19 suffering from AKI were the history of diabetes, hypertension, and hyperlipidemia. Twelve out of the 44 included studies reported a history of chronic kidney disease (CKD) in this group of patients. Focal segmental glomerulosclerosis (FSGS) and acute tubular necrosis (ATN) were the most common pathological evidence. The average length of hospital stay was 19 days, and the average duration of need for mechanical ventilation was 3 days.
Conclusions: The current systematic review shows that AKI frequently complicates the course of COVID-19 hospitalizations and is associated with increased severity of illness, prolonged duration of hospitalization, and poor prognosis. Given the extent of the adverse impact of AKI, early detection of comorbidities and renal complications is essential to improve the outcomes of COVID-19 patients.

Keywords: AKI; COVID-19; SARS-CoV-2; acute kidney injury; systematic review.
 
Back
Top Bottom